Literature DB >> 15549590

Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil.

Ayumu Hosokawa1, Yasuhide Yamada, Yasuhiro Shimada, Kei Muro, Tetsuya Hamaguchi, Hideko Morita, Mari Araake, Hiromi Orita, Kuniaki Shirao.   

Abstract

BACKGROUND: This study was conducted to evaluate the prognostic significance of thymidylate synthase (TS) expression in the tumor tissue of patients with metastatic colorectal cancer (CRC) who received protracted venous infusions of 5-fluorouracil (5-FU).
METHODS: We retrospectively analyzed the prognostic value of TS expression as compared with other clinical prognostic factors in 57 patients with metastatic CRC.
RESULTS: On univariate analysis, survival was significantly related to TS expression (low vs high; P = 0.0015), alkaline phosphatase (ALP) level (<300 vs > or =300 IU/l; P = 0.0037), performance status (0 or 1 vs 2 or 3; P = 0.0073), and white blood cell count (<10,000/mm3 vs > or =10,000/mm3; P = 0.0001), with number of metastatic sites (1 vs > or =2; P = 0.06) approaching significance. On multivariate analysis, survival was significantly related to TS expression (hazard ratio [HR], 2.97) and ALP level (HR, 2.26).
CONCLUSION: In patients with metastatic CRC who received protracted venous infusions of 5-FU, TS expression was related to survival independently of other established clinical prognostic factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549590     DOI: 10.1007/s10147-004-0425-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  4 in total

1.  Identification of long non-coding RNA SCARNA9L as a novel molecular target for colorectal cancer.

Authors:  Jie Chai; Jianbo Zhang; Dali Han; Wei Dong; Li Han; Lei Zou; Bin Feng; Baosheng Li; Wanli Ma
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

Review 2.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression.

Authors:  Avo Artinyan; Rahila Essani; Jeffrey Lake; Andreas M Kaiser; Peter Vukasin; Peter Danenberg; Kathleen Danenberg; Robert Haile; Robert W Beart
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

4.  Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer.

Authors:  Anastasios Ntavatzikos; Aris Spathis; Paul Patapis; Nikolaos Machairas; George Peros; Stefanos Konstantoudakis; Danai Leventakou; Ioannis G Panayiotides; Petros Karakitsos; Anna Koumarianou
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.